Simulation of nanodrug by theoretical approach

被引:16
作者
Ghorbaninezhad S. [1 ]
Ghorbaninezhad M. [1 ]
机构
[1] Department of Chemistry, Islamic Azad University (Rasht Branch), Rasht
关键词
Anti-HIV; Chalcone; DFT; Inhibitor; Nanodrug; Nanotube; NBO; SWCNT;
D O I
10.1186/2193-8865-3-53
中图分类号
学科分类号
摘要
In recent years, HIV-1 integrase (IN) has become an attractive target for designing antiretroviral agents. The development of raltegravir and other successful lead IN inhibitors has also influenced the IN inhibitor design strategy. This has led to the identification of several potent inhibitors in these last 2 years. The medicines which have the compound of C-centered and N-centered anti-HIV inhibitor with single-walled carbon nanotube are examined by density functional theory (DFT) method. In this paper, the end of the nanotubes, which was saturated with hydrogen atoms, was examined by DFT at the level of B3LYP and 6-31G(d) standard basis set. There are free Gibbs energy, free Helmholtz energy, enthalpy, bond length (Å), bond angle (in degrees), dihedral angle (in degrees), energy hyperconjugation, total energy (in Kcal mol−1), moment dipole (in Debye), occupancy between nanotube (6, 6), and chalcone derivative. These cases and medicines show that complex 2 is more stable than the other complexes. © 2013, Ghorbaninezhad and Ghorbaninezhad; licensee Springer.
引用
收藏
相关论文
共 23 条
[1]  
Iijima S., Helical microtubules of graphitic carbon, Nature, 354, (1991)
[2]  
Colomer J.F., Henrard L., Lambin P., Van Tendeloo G., Electron diffraction study of small bundles of single-wall carbon nanotubes with unique helicity, Physic Rev B, 64, (2001)
[3]  
Pouton C.W., Seymour L.W., Key issues in non-viral gene delivery, Adv. Drug Deliv. Rev, 46, pp. 187-203, (2001)
[4]  
Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., Bianco A., Kostarelos K., Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers, Proc. Natl. Acad. Sci. USA, 103, pp. 3357-3362, (2006)
[5]  
Wong Shi Kam N., Jessop T.C., Wender P.A., Dai H., Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells, J. Am. Chem. Soc, 126, pp. 6850-6851, (2004)
[6]  
Pastorin G., Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option?, Pharm. Res, 26, pp. 746-769, (2009)
[7]  
Taft B.J., Lazareck A.D., Withey G.D., Yin A., Xu J.M., Kelley S.O., Site-specific assembly of DNA and appended cargo on arrayed carbon nanotubes, J. Am. Chem. Soc, 126, pp. 12750-12751, (2004)
[8]  
Pantarotto D., Singh R., McCarthy D., Erhardt M., Briand J.P., Prato M., Kostarelos K., Bianco A., Functionalized carbon nanotubes for plasmid DNA gene delivery, Angew. Chem. Int. Ed, 43, pp. 5236-5242, (2004)
[9]  
Cato M.H., D'Annibale F., Mills D.M., Cerignoli F., Dawson M.I., Bergamaschi E., Bottini N., Magrini A., Bergamaschi A., Rosato N., Rickert R.C., Mustelin T., Bottini M., Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies, J. Nanosci. Nanotechnol, 8, pp. 2259-2269, (2008)
[10]  
Gannon C.J., Cherukuri P., Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field, Cancer, 110, pp. 2654-2665, (2007)